4 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 4 mutual funds hold active equity positions in both Gland Pharma and Rishabh Instruments. The scheme with the highest combined exposure is quant Small Cap Fund (Quant MF), which holds a 0.82% stake in Gland Pharma and a 0.32% stake in Rishabh Instruments, amounting to a combined conviction weight of 1.13%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Gland wt. | Rishabh wt. | Combined |
|---|---|---|---|
| quant Small Cap FundQuant MF · Small Cap | 0.82% | 0.32% | |
| Nippon India Flexi Cap FundNippon India MF · Flexi Cap | 0.95% | 0.18% | |
| Nippon India Small Cap FundNippon India MF · Small Cap | 0.59% | 0.13% | |
| HDFC Dividend Yield FundHDFC MF · Dividend Yield | 0.40% | 0.13% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.